AV
Atlas Venture Fund XI, L.P.
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Insider active across 2 companies, notably Korro Bio, Inc.. In total, 12 reports have been recorded. History available since 22 June 2026. The latest transaction was disclosed on 7 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
153,966 shares@ US$22.840.089% mcap37.6% of flowCommonSEC144:0001628280-26-047533
817 shares@ US$14.000.0056% mcap1.0% of flowCommon StockSEC144:0001628280-26-047352
253,039 shares@ US$23.070.15% mcap62.4% of flowCommonSEC144:0001628280-26-047357
85,955 shares@ US$13.650.55% mcap100.0% of flowCommon StockSEC144:0001628280-26-046978
102,969 shares@ US$20.940.056% mcap14.5% of flowCommonSEC144:0001628280-26-046094
162,954 shares@ US$20.610.087% mcap22.7% of flowCommonSEC144:0001628280-26-045819
12,699 shares@ US$20.33CommonSEC144:0001628280-26-045611
50,530 shares@ US$20.26CommonSEC144:0001628280-26-045293
41,345 shares@ US$13.71Common StockSEC144:0001628280-26-045302
101,579 shares@ US$13.90Common StockSEC144:0001628280-26-044982
77,855 shares@ US$20.87CommonSEC144:0001628280-26-044986
21,339 shares@ US$12.99Common StockSEC144:0001628280-26-044738
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. is a declarant and a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. In the sampled recent filings, it recorded sales only, totaling EUR 9213415, between 2026-07-02 and 2026-07-07. The total number of filings is 4, and the modal transaction nature is Notice of proposed sale (Form 144).